Cancelled by the investigator A multicentre, randomized, controlled trial for the Ba-Duan-Jin in the adjunctive treatment of patients with common type novel coronavirus pneumonia (COVID-19)

INTERVENTION: treatment group :Ba duanjin; CONDITION: novel common type of coronavirus pneumonia INCLUSION CRITERIA: (1) age: 18‐75 years old (including threshold), regardless of gender; (2) compliance with the pneumonia diagnosis and treatment protocol for novel coronavirus infection ‐ the diagnostic criteria for the trial version 6 (the latest version, which is currently updated to version 6). (3) the sixth version of the reference treatment scheme meets the common type standard; (4) no participation in traditional health exercise (ba duan jin, tai chi, wu qin xi or other fitness qigong) within 7 days; (5) steady gait and clear consciousness; (6) patients who agreed to participate in this study and voluntarily signed the informed consent.